Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on November 6, 2024, reports on the Third Quarter of 2024 for Cellebrite DI Ltd., a foreign private issuer headquartered in Petah Tikva, Israel. The filing serves to distribute a press release titled "Cellebrite Announces Third-Quarter 2024 Results" to U.S. investors.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and are incorporated by reference into the company's registration statements on Form S-8 and Form F-3.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not include specific details on guidance, outlook, management commentary, risks, contingencies, or unusual items. Such information is expected to be detailed in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2024 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check the press release for updated full-year 2024 guidance and management commentary.
- Confirm any new risk factors or contingencies disclosed in the Q3 results announcement.